Correlation Between Ultragenyx and Incyte
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Incyte, you can compare the effects of market volatilities on Ultragenyx and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Incyte.
Diversification Opportunities for Ultragenyx and Incyte
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ultragenyx and Incyte is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Ultragenyx i.e., Ultragenyx and Incyte go up and down completely randomly.
Pair Corralation between Ultragenyx and Incyte
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the Incyte. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.3 times less risky than Incyte. The stock trades about -0.12 of its potential returns per unit of risk. The Incyte is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 6,631 in Incyte on September 2, 2024 and sell it today you would earn a total of 828.00 from holding Incyte or generate 12.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ultragenyx vs. Incyte
Performance |
Timeline |
Ultragenyx |
Incyte |
Ultragenyx and Incyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ultragenyx and Incyte
The main advantage of trading using opposite Ultragenyx and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Incyte vs. Tff Pharmaceuticals | Incyte vs. Eliem Therapeutics | Incyte vs. Inhibrx | Incyte vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements |